Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Abstract

The use of an aerosolizable form of anthrax as a biological weapon is considered to be among the most serious bioterror threats. Intranasal (IN) delivery of a dry powder anthrax vaccine could provide an effective and non-invasive administration alternative to traditional intramuscular (IM) or subcutaneous (SC) injection. We evaluated a dry powder vaccine… (More)

Topics

Cite this paper

@article{Huang2007IntranasalAO, title={Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.}, author={Joanne Huang and John A. Mikszta and Matthew S Ferriter and Ge Jiang and Noel G. Harvey and Beverly K. Dyas and Chad J Roy and Robert G. Ulrich and Vincent J. Sullivan}, journal={Human vaccines}, year={2007}, volume={3 3}, pages={90-3} }